Logo image of DCGO

DOCGO INC (DCGO) Stock Fundamental Analysis

USA - NASDAQ:DCGO - US2560861096 - Common Stock

1.55 USD
+0.07 (+4.73%)
Last: 9/18/2025, 8:00:01 PM
1.55 USD
0 (0%)
After Hours: 9/18/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to DCGO. DCGO was compared to 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for DCGO as it has an excellent financial health rating, but there are worries on the profitability. DCGO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DCGO has reported negative net income.
In the past year DCGO had a positive cash flow from operations.
DCGO had positive earnings in 4 of the past 5 years.
In multiple years DCGO reported negative operating cash flow during the last 5 years.
DCGO Yearly Net Income VS EBIT VS OCF VS FCFDCGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.49%, DCGO is doing worse than 65.35% of the companies in the same industry.
DCGO has a Return On Equity (-6.16%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.49%
ROE -6.16%
ROIC N/A
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
DCGO Yearly ROA, ROE, ROICDCGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

In the last couple of years the Profit Margin of DCGO has declined.
In the last couple of years the Operating Margin of DCGO has declined.
DCGO's Gross Margin of 33.65% is fine compared to the rest of the industry. DCGO outperforms 64.36% of its industry peers.
DCGO's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.65%
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
DCGO Yearly Profit, Operating, Gross MarginsDCGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DCGO has less shares outstanding
DCGO has a worse debt/assets ratio than last year.
DCGO Yearly Shares OutstandingDCGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DCGO Yearly Total Debt VS Total AssetsDCGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

DCGO has an Altman-Z score of 1.98. This is not the best score and indicates that DCGO is in the grey zone with still only limited risk for bankruptcy at the moment.
DCGO has a Altman-Z score (1.98) which is comparable to the rest of the industry.
The Debt to FCF ratio of DCGO is 0.58, which is an excellent value as it means it would take DCGO, only 0.58 years of fcf income to pay off all of its debts.
DCGO's Debt to FCF ratio of 0.58 is amongst the best of the industry. DCGO outperforms 91.09% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that DCGO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.14, DCGO is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.58
Altman-Z 1.98
ROIC/WACCN/A
WACC8.45%
DCGO Yearly LT Debt VS Equity VS FCFDCGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

DCGO has a Current Ratio of 2.36. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of DCGO (2.36) is better than 79.21% of its industry peers.
A Quick Ratio of 2.36 indicates that DCGO has no problem at all paying its short term obligations.
DCGO's Quick ratio of 2.36 is amongst the best of the industry. DCGO outperforms 80.20% of its industry peers.
Industry RankSector Rank
Current Ratio 2.36
Quick Ratio 2.36
DCGO Yearly Current Assets VS Current LiabilitesDCGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -137.93%.
DCGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
DCGO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.31%.
DCGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.60% yearly.
EPS 1Y (TTM)-137.93%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-257.14%
Revenue 1Y (TTM)-41.31%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-51.25%

3.2 Future

The Earnings Per Share is expected to decrease by -39.69% on average over the next years. This is quite bad
The Revenue is expected to decrease by -17.73% on average over the next years. This is quite bad
EPS Next Y-259.54%
EPS Next 2Y-62.96%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue Next Year-49.13%
Revenue Next 2Y-28.84%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DCGO Yearly Revenue VS EstimatesDCGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
DCGO Yearly EPS VS EstimatesDCGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DCGO. In the last year negative earnings were reported.
Also next year DCGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCGO Price Earnings VS Forward Price EarningsDCGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.86
EV/EBITDA N/A
DCGO Per share dataDCGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A cheap valuation may be justified as DCGO's earnings are expected to decrease with -39.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-62.96%
EPS Next 3Y-39.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DCGO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOCGO INC

NASDAQ:DCGO (9/18/2025, 8:00:01 PM)

After market: 1.55 0 (0%)

1.55

+0.07 (+4.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners54.74%
Inst Owner Change-12.74%
Ins Owners6.91%
Ins Owner Change0.57%
Market Cap151.61M
Analysts78.46
Price Target3.14 (102.58%)
Short Float %4.46%
Short Ratio9.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-163.06%
Min EPS beat(2)-311.74%
Max EPS beat(2)-14.37%
EPS beat(4)1
Avg EPS beat(4)-86.11%
Min EPS beat(4)-311.74%
Max EPS beat(4)0.93%
EPS beat(8)2
Avg EPS beat(8)-48.05%
EPS beat(12)3
Avg EPS beat(12)-63.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.02%
Min Revenue beat(2)-9.68%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.48%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)4
Avg Revenue beat(8)0.77%
Revenue beat(12)7
Avg Revenue beat(12)1.29%
Revenue beat(16)10
Avg Revenue beat(16)9.13%
PT rev (1m)0.82%
PT rev (3m)0.82%
EPS NQ rev (1m)-19.12%
EPS NQ rev (3m)-87.93%
EPS NY rev (1m)-19.61%
EPS NY rev (3m)-559.43%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)2.35%
Revenue NY rev (1m)1.12%
Revenue NY rev (3m)1.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF 1.86
P/OCF 1.74
P/B 0.51
P/tB 0.69
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)0.83
FCFY53.64%
OCF(TTM)0.89
OCFY57.5%
SpS4.46
BVpS3.04
TBVpS2.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.49%
ROE -6.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.65%
FCFM 18.65%
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score5
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.58
Debt/EBITDA N/A
Cap/Depr 38.46%
Cap/Sales 1.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.36
Quick Ratio 2.36
Altman-Z 1.98
F-Score5
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.93%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-257.14%
EPS Next Y-259.54%
EPS Next 2Y-62.96%
EPS Next 3Y-39.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-41.31%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-51.25%
Revenue Next Year-49.13%
Revenue Next 2Y-28.84%
Revenue Next 3Y-17.73%
Revenue Next 5YN/A
EBIT growth 1Y-153.15%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-157.05%
EBIT Next 3Y-27.25%
EBIT Next 5YN/A
FCF growth 1Y457.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y734.5%
OCF growth 3YN/A
OCF growth 5YN/A